Novel combinations yield promising results for leukemia patients with poor prognoses

Recognizing that leukemia cannot be conquered with a 'one-size-fits-all' approach, researchers are pursuing novel targeted therapies and combinations of existing treatment regimens with new agents for patient populations with historically poor prognoses, according to new data.